ATS 2024 Final Program

Click on the session title to view the speakers

138

MONDAY • MAY 20

P956 TLR4 Inhibition Does Not Improve Mortality Due to Intermittent Hypoxia in a Mouse Model of COVID-19 P957 Increased Circulating Nucleosomes and Their Potential Contribution to Inflammation in COVID-19 Patients P958 Comprehensive Analysis of Bronchoalveolar Lavage Fluid by Validating ELISA and MSD Systems for 23 Biomarkers P959 Vitamin B12: A Potential Marker for Infection and Sepsis P960 OC43 Coronavirus Infection of the Mouse Lung Induces OC43-specific Systemic and Resident Memory, Boosted by Cyclic-di-GMP P961 ARBM-201 as a Novel Pendrin Inhibitor, Limiting Excess Pro-inflammatory Responses in Lung Cells In Vitro P962 Functional Neutrophil Phenotypes in Murine Models of Acute Lung Injury

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B33 COVID-19, LUNG INJURY, AND SEPSIS 9:15 a.m. - 4:15 p.m. San Diego Convention Center Area I (Hall H, Ground Level) Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P945 Mortality-associated Protein Signatures Shared Across Sepsis and COVID-19 Include Potential Mediators of Lung Injury and Repair P946 Acute Kidney Injury Contributes to Increased Circulating Mitochondrial DNA in Sepsis P947 Streamlined Nucleus Isolation Protocol for Cryopreserved Mouse Lung Captures Non-immune Cell Types by Single-nucleus RNA Sequencing P948 The Novel Mechanism of Action of GEn-1124, A Next-generation Non-catalytic P38alpha/MK2 Signal Modifier With Endothelial-barrier-stabilizing, Anti-inflammatory, and Lung-protective Activities P949 Mechanisms of eNAMPT Secretion Upon Inflammasome Activation P950 A Single-dose Phase 1 Study With SLV213 Demonstrates Safety and Pharmacokinetics Enabling Investigation of a New Orally Available Cathepsin L Inhibitor for Treatment of Patients With Respiratory Diseases P951 The Role of Treg-expressed Mmp12 During the Resolution of Acute Lung Injury P952 Cigarette Smoke Suppress GALNT2 Expression in Lungs of SARS-CoV-2-infected Mice P953 Associations of Asthma and Type 2 Inflammation With Symptom Burden in Patients Post-COVID-19 P954 Neutrophil Activation and Their Derived NETs Contribute to Thrombotic Risk in Post-acute Sequelae of SARS-CoV-2 Patients With Persistent Respiratory Symptoms P955 Activity of Glutathione-related Enzyme System in Patients With Community-acquired Pneumonia Comorbid With Non-alcoholic Fatty Liver Disease

BEHAVIORAL THEMATIC POSTER SESSION

B34 PROVIDER-CENTERED HEALTH SERVICES RESEARCH 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area E (Hall A-B2, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P411 Underrepresentation of International Medical Graduates in Academic Leadership in Pulmonary Disease and Critical Care Medicine P412 Evaluation of the Respiratory Therapy Profession in Ghana: A Cross-sectional Study P413 A Needs Assessment to Address Provider Burnout in the Hospital P414 Sense of Calling and Autonomy Among Saudi Respiratory Therapists: Cross-sectional Study P415 Mid-level Providers (MLPs) in the Ed: Where Is the Optimum Balance?

ATS 2024 Conference Program • San Diego, CA